Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Post by SouthernTierTomon Feb 04, 2021 3:25pm
105 Views
Post# 32472918

Good points! Let's put "New professional US IR" at the top

Good points! Let's put "New professional US IR" at the top of our list!  I love this collaboration....too bad Domino didn't sign up 20 years ago !!

Never too late to made a "good friend" ; - )

List of events and recent accomplishments;

* US IR - as per Domino !!!! - cheers pal!

* Full FDA approval for wholly-owned EAA diagnostic


* FULL not "EUA" FDA PMX ( blood filtration device ) approval for CV19 in US

* FULL Canada Health PMX approval for CV19

* FULL FDA approval for SAMI device

* FDA approval for DIMI device ( home dialysis pending on FDA home study detail )

* 6.5 MILLION CAD from Baxter for selling partnership arrangement - no strings / no surrender of  any company value.

* Pending FULL Canadien DIMI approval with detail to come iminently

* Data from 179 ( 194-16 CAD sites + 1 ) patients identified as usable data from phase 3 trial, to carry substantial weight in TIGRIS approval 

TIGRIS phase 3B/4 confirmatory trial that boasts a 2:1 in favor of our propsed PMX blood filtration device ( used safely and efficacously on over 200,000 patients in Japan and the EU )  * this was a 10 site trial expanded to 15 - Interim analysis H2 2021

* CV19 trial initially 2 sites expanded to 3 ( Conn , NY, Mass ) and expected to look at 75 patients - approaching one year mark - covid trial, expect covid didn't reduce recruitmrent

* Recent finance at 60 cents ( 11 new institutional players ) and 45 cent warrants to come due April/21 to add to adequate cash position

* Consolidation of 10 for 1 approved at last AGM ( by those able to vote )

* January 2021 hire of US invester realtions firm - see next point!

* Awaiting 2020 financials to make the move to a "senior US listing"  

* Options are due to be issued in days to weeks - new hire and BoD etc..

* NO other serious competition in our space.  NOBODY has the FDA advancement of us when it comes to the treatment of an endotoxemic septic shock patient....

* It looks quite interesting, I know I've been "offered up some alternatives, but I like this one for that "spectralative 3 to 5% of my portfoeleo.

* Always do your own homework and consult a pro in matters $50 USD or $100 CAD

Please feel free to add, perhaps a word or two from the long side?

Bon chance amigos!  Let's see what happens when word on this gem escapes the tiny world of Ithaca and specificallty the STIG ( Southern tier investment group ) and goes "viral" ( aka to 100 or so Yanks )

Best to all and let's be friends fellas..we are ALL here for each other to share ideas and learn about our investment..  .

Add to the list...we welcome ALL ; -)

Tommy A Tractor
<< Previous
Bullboard Posts
Next >>